Module 1 of 5

Measuring skin disease

How skin disease is measured in trials: area, global assessments, responder endpoints and patient reports.

Lecture for Module 1. Open the playlist on YouTube

Key points

  • The area of one hand is about 1 percent of body surface area (EMA psoriasis guideline).
  • An IGA rates overall severity on a defined ordinal scale; vIGA-AD runs 0 (clear) to 4 (severe) (Simpson 2020).
  • A static assessment rates the disease at the visit, without reference to baseline.
  • A responder endpoint such as EASI-75 is a binary outcome against a prespecified threshold.
  • A PRO comes directly from the patient, without interpretation by anyone else (FDA PRO guidance).
  • The MCID is the smallest change patients perceive as meaningful (Basra 2015).

Reading for this module

Module 1 quiz

10 questions. Pass mark: 9 of 10. Questions and answers are shuffled each time, and you see the explanations when you finish.